English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT.    Methods  Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by subcutaneous transplantation of two human non-small-cell lung cancer (NSCLC) cells (A549, H1299) either alone or co-transplanted with vascular growth promoters. The vascularity of the tumours was assessed noninvasively by MRI diffusion-weighted-imaging (DWI), T2-weighted, and time-of-flight (TOF) sequences) as well as contrast-enhanced CT (CE-CT), using clinical scanners. As a reference standard, histological examinations (CD-31, fluorescent beads) were done after explantation.    Results  Microvessel density (MVD) was higher in co-transplanted tumours (171 ± 19 number/mm 2 ) than in non-co-transplanted tumours (111 ± 11 number/mm 2 ;  p  = 0.002). Co-transplanted tumours showed higher growth rates and larger tumour vessels at TOF-MRI as well as larger necrotic areas at CE-CT. In co-transplanted tumours, DWI revealed higher cellularity (lower minimal ADC diff  166 ± 15 versus 346 ± 27 mm 2 /s × 10 −6 ;  p  < 0.001), highly necrotic areas (higher maximal ADC diff  1695 ± 65 versus 1320 ± 59 mm 2 /s × 10 −6 ;  p  < 0.001), and better-perfused tumour stroma (higher ADC perf  723 ± 36 versus 636 ± 51 mm 2 /s × 10 −6 ;  p  = 0.005). Significant correlations were found using qualitative and quantitative parameters: maximal ADC perf  and MVD ( r  = 0.326); maximal ADC diff  and relative necrotic volume on CE-CT ( r  = 0.551); minimal ADC diff  and MVD ( r  = −0.395).    Conclusions  Pathophysiological differences related to vascular supply in two human lung cancer cell lines with modifiable vascularity are quantifiable with clinical imaging techniques. Imaging parameters of vascularisation correlated with the results of histology. DWI was able to characterise both the extent of necrosis and the level of perfusion.

european radiology experimental

Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study